Amgen to Invest $600M in New Science Innovation Center at HQ

Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs 

THOUSAND OAKS, Calif., Sept. 2, 2025 /PRNewswire/ — Amgen (NASDAQ: AMGN) in the present day introduced plans to make investments greater than $600 million in a brand new, state-of-the-art heart for science and innovation at its international headquarters in Thousand Oaks, California.

The heart is designed to carry collectively researchers, engineers and scientists throughout disciplines to improve collaboration and speed up the invention of next-generation therapeutics for sufferers with probably the most severe ailments. The constructing will function superior automation and digital capabilities, empowering scientists with the instruments and setting wanted to drive scientific excellence and developments in biotechnology.

Amgen’s long-standing dedication to U.S. innovation and state-of-the-art operations is mirrored in greater than $40 billion invested in manufacturing and analysis and improvement because the passage of the Tax Cuts and Jobs Act (TCJA) of 2017. This funding contains over $5 billion in direct capital expenditures in the U.S. The enactment of pro-growth tax insurance policies in TCJA, prolonged and bolstered by the One Big Beautiful Bill Act of 2025, additional facilitates Amgen’s means to make investments domestically in cutting-edge science and manufacturing.

“At Amgen, we’re continuing to invest in the future of American science and innovation,” mentioned Robert A. Bradway, chairman and chief govt officer at Amgen. “This new center will empower our scientists with the tools and collaborative environment they need to shape the next era of scientific discovery and advance medicines that improve human health.”

The new heart for science and innovation enhances the corporate’s international community of web sites, leveraging many years of operational experience and technological developments.

Construction is anticipated to start in Q3 2025 and create lots of of U.S. jobs. Amgen has been headquartered in Thousand Oaks, California, a part of the larger Los Angeles area, because the firm’s founding greater than 45 years in the past.

The announcement builds on different current investments from the corporate together with a $900 million enlargement of its manufacturing facility in Central Ohio and a $1 billion funding to construct a second manufacturing plant in Holly Springs, North Carolina.

About Amgen 
Amgen discovers, develops, manufactures and delivers modern medicines to assist thousands and thousands of sufferers in their battle towards a number of the world’s hardest ailments. More than 40 years in the past, Amgen helped to set up the biotechnology trade and stays on the cutting-edge of innovation, utilizing expertise and human genetic information to push past what’s recognized in the present day. Amgen is advancing a broad and deep pipeline that builds on its current portfolio of medicines to deal with most cancers, coronary heart illness, osteoporosis, inflammatory ailments and uncommon ailments.

In 2024, Amgen was named one of many “World’s Most Innovative Companies” by Fast Company and considered one of “America’s Best Large Employers” by Forbes, amongst different external recognitions. Amgen is likely one of the 30 firms that comprise the Dow Jones Industrial Average^®, and additionally it is a part of the Nasdaq-100 Index^®, which incorporates the most important and most modern non-financial firms listed on the Nasdaq Stock Market primarily based on market capitalization.

For extra info, go to Amgen.com and observe Amgen on X, LinkedIn, Instagram, YouTube and Threads. 

Amgen Forward-Looking Statements
This information launch incorporates forward-looking statements which can be primarily based on the present expectations and beliefs of Amgen. All statements, aside from statements of historic reality, are statements that could possibly be deemed forward-looking statements, together with any statements on the end result, advantages and synergies of collaborations, or potential collaborations, with every other firm (together with BeOne Medicines Ltd. or Kyowa Kirin Co., Ltd.), the efficiency of Otezla® (apremilast), our acquisitions of ChemoCentryx, Inc. or Horizon Therapeutics plc (together with the potential efficiency and outlook of Horizon’s enterprise, efficiency and alternatives, and any potential strategic advantages, synergies or alternatives anticipated because of such acquisition), in addition to estimates of revenues, working margins, capital expenditures, money, different monetary metrics, anticipated authorized, arbitration, political, regulatory or scientific outcomes or practices, buyer and prescriber patterns or practices, reimbursement actions and outcomes, results of pandemics or different widespread well being issues on our enterprise, outcomes, progress, and different such estimates and outcomes. Forward-looking statements contain vital dangers and uncertainties, together with these mentioned under and extra absolutely described in the Securities and Exchange Commission experiences filed by Amgen, together with our most up-to-date annual report on Form 10-Ok and any subsequent periodic experiences on Form 10-Q and present experiences on Form 8-K. Unless in any other case famous, Amgen is offering this info as of the date of this information launch and doesn’t undertake any obligation to replace any forward-looking statements contained in this doc because of new info, future occasions or in any other case.

No forward-looking assertion may be assured and precise outcomes might differ materially from these we venture. Our outcomes could also be affected by our means to efficiently market each new and current merchandise domestically and internationally, scientific and regulatory developments involving present and future merchandise, gross sales development of not too long ago launched merchandise, competitors from different merchandise together with biosimilars, difficulties or delays in manufacturing our merchandise and international financial situations, together with these ensuing from geopolitical relations and authorities actions. In addition, gross sales of our merchandise are affected by pricing stress, political and public scrutiny and reimbursement insurance policies imposed by third-party payers, together with governments, non-public insurance policy and managed care suppliers and could also be affected by regulatory, scientific and guideline developments and home and worldwide traits towards managed care and healthcare value containment. Furthermore, our analysis, testing, pricing, advertising and marketing and different operations are topic to in depth regulation by home and overseas authorities regulatory authorities. We or others may establish security, unwanted side effects or manufacturing issues with our merchandise, together with our units, after they’re available on the market. Our enterprise could also be impacted by authorities investigations, litigation and product legal responsibility claims. In addition, our enterprise could also be impacted by the adoption of latest tax laws or publicity to extra tax liabilities. Further, whereas we routinely get hold of patents for our merchandise and expertise, the safety supplied by our patents and patent functions could also be challenged, invalidated or circumvented by our rivals, or we might fail to prevail in current and future mental property litigation. We carry out a considerable quantity of our industrial manufacturing actions at a couple of key services, together with in Puerto Rico, and likewise rely upon third events for a portion of our manufacturing actions, and limits on provide might constrain gross sales of sure of our present merchandise and product candidate improvement. An outbreak of illness or comparable public well being menace, and the general public and governmental effort to mitigate towards the unfold of such illness, may have a major adversarial impact on the provision of supplies for our manufacturing actions, the distribution of our merchandise, the commercialization of our product candidates, and our scientific trial operations, and any such occasions might have a cloth adversarial impact on our product improvement, product gross sales, enterprise and outcomes of operations. We depend on collaborations with third events for the event of a few of our product candidates and for the commercialization and gross sales of a few of our industrial merchandise. In addition, we compete with different firms with respect to lots of our marketed merchandise in addition to for the invention and improvement of latest merchandise. Discovery or identification of latest product candidates or improvement of latest indications for current merchandise can’t be assured and motion from idea to product is unsure; consequently, there may be no assure that any explicit product candidate or improvement of a brand new indication for an current product can be profitable and grow to be a industrial product. Further, some uncooked supplies, medical units and element elements for our merchandise are provided by sole third-party suppliers. Certain of our distributors, prospects and payers have substantial buying leverage in their dealings with us. The discovery of great issues with a product comparable to considered one of our merchandise that implicate a whole class of merchandise may have a cloth adversarial impact on gross sales of the affected merchandise and on our enterprise and outcomes of operations. Our efforts to collaborate with or purchase different firms, merchandise or expertise, and to combine the operations of firms or to help the merchandise or expertise we have now acquired, is probably not profitable. There may be no assure that we are going to have the opportunity to understand any of the strategic advantages, synergies or alternatives arising from the Horizon acquisition, and such advantages, synergies or alternatives might take longer to understand than anticipated. We is probably not ready to efficiently combine Horizon, and such integration might take longer, be tougher or value greater than anticipated. A breakdown, cyberattack or info safety breach of our info expertise methods may compromise the confidentiality, integrity and availability of our methods and our information. Our inventory value is unstable and could also be affected by various occasions. Our enterprise and operations could also be negatively affected by the failure, or perceived failure, of reaching our sustainability aims. The results of world local weather change and associated pure disasters may negatively have an effect on our enterprise and operations. Global financial situations might amplify sure dangers that have an effect on our enterprise. Our enterprise efficiency may have an effect on or restrict the power of our Board of Directors to declare a dividend or our means to pay a dividend or repurchase our widespread inventory. We is probably not ready to entry the capital and credit score markets on phrases which can be favorable to us, or at all.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Adam Elinoff, 805-313-6285 (buyers) 

View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/amgen-investing-more-than-half-a-billion-dollars-in-new-state-of-the-art-center-for-science-and-innovation-at-us-global-headquarters-302542364.html

SOURCE Amgen